WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

MNC's County-Level Ambitions Falter as Strategies Shift From Heavy Investment ... Novartis, AstraZeneca, and Eli Lilly are among a growing list of MNCs undergoing a significant strategic reset in China's county-level healthcare market. After years of a...
(12/1/2025)

China Launches National Drug Price Registratio... (12/2/2025)

NHC Releases 2024 China Health Statistics Bull... (12/2/2025)

China Used to Be a Cash Cow for Western Compan... (12/2/2025)

MNC's County-Level Ambitions Falter as Strateg... (12/1/2025)

LEK: China's Clinical Trial Sector Enters a Ne... (11/28/2025)

MC's China Biopharma Tracker: Dealmaking, Appr... (11/27/2025)

China's Biopharma Innovation Surges — McKinse... (11/21/2025)

US Report Flags Risks From China's Expanding C... (11/21/2025)

China Biopharma Tracker – October 2025 (Pharm... (11/20/2025)

China's Innovation-drug BD Boom Slows as Inves... (11/20/2025)

China's October Approvals Signal the Next Five... (11/18/2025)

China Biopharma Strikes Record USD 19.9 B in L... (11/18/2025)

Recent Executive Moves (12/5/2025) Highlightll Pharma Files for Hong Kong I... (12/5/2025) OTR Thera Secures US$100M in Series A Fi... (12/5/2025) China Issues Revised Guideline on Gradin... (12/5/2025) China Releases 99th Batch of Reference F... (12/5/2025) Takeda Closes Strategic Partnership with... (12/5/2025) ARCH, Lilly Asia Ventures Return to Back... (12/5/2025) Kelun-Biotech and Crescent Biopharma For... (12/5/2025) China's Healthcare Costs Shift to Indivi... (12/4/2025) Simcere Secures Greater China Rights to... (12/4/2025) Lynk Receives FDA IND Approval for Its B... (12/4/2025) CDE Seeks Comments on Draft Guidelines D... (12/3/2025) L&L Bio Completes Series B++ Financing t... (12/3/2025) WuXi Biologics Extends Global CRDMO Netw... (12/3/2025) Fangzhou and Tencent Launch Full-Stack A... (12/2/2025) 3SBio Seeks HK$3.12B in HK Share Placeme... (12/2/2025) Proviva Raises Over US$30M to Advance Ne... (12/2/2025) Lynk Pharma Files for Hong Kong IPO to A... (12/2/2025)

China's Pharmaceutical Market Enters a New Consumer-Dri... China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i... China's PD-(L)1 Market Shows Continued Growth in H1 202...

Kelun-Biotech and Crescent Biopharma Forge Strategic Al... ARCH, Lilly Asia Ventures Return to Back US–China Star... Takeda Closes Strategic Partnership with Innovent Biolo... OTR Thera Secures US$100M in Series A Financing Highlightll Pharma Files for Hong Kong IPO as It Expand...

China Releases 99th Batch of Reference Formulations Cat... China Issues Revised Guideline on Grading Adverse Event... CDE Seeks Comments on Draft Guidelines Defining Major D... CDE Solicits Comments on Draft Guidance for Computerize... NMPA Issues New Rules on Inspections and Export Certifi...

China's Healthcare Costs Shift to Individuals as Govern... China Expands Grassroots Healthcare Access with More Do... China Pilots Next-Generation AI Reforms Across Public H... NHC Issues the Guidelines for Strengthening Service Cap... China Launches National Strategy to Integrate AI Across...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S... Sanofi Launches €1B Insulin API Manufacturing Project ... China Faces New Pressure as U.S. Eyes Middle East for D...

Lynk Receives FDA IND Approval for Its Brain-Penetrant ... Innovent's Pecondle Wins China Approval as First Homegr... New ADC Shows Broad Antitumor Activity With Strong Byst... BeOne Secures USFDA Priority Review for Sonrotoclax Zhongmou Reports Strong First-in-Human Results for Opto...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Former NMPA Deputy Head Prosecuted for Bribery Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...